基于超声心动图评估的心脏重塑与经皮冠状动脉介入治疗术后急性肾损伤的相关性分析

Correlation between cardiac remodeling and acute renal function injury after percutaneous coronary intervention based on echocardiography evaluation

  • 摘要:
    目的 探讨超声心动图参数评估的心脏重塑与发生造影剂相关性急性肾损伤(CA-AKI)的关联性。
    方法 回顾性分析2021年3月-2024年3月接受冠状动脉造影(CAG)和经皮冠状动脉介入治疗(PCI)的100例冠状动脉疾病(CAD)患者的临床数据。按是否发生CA-AKI将患者分成CA-AKI组和非CA-AKI组, 收集并比较2组基线资料及超声心动图参数, 包括左心室舒张末期内径指数(LVIDDI)、左心室收缩末期内径指数(LVIDSI)和左心室质量指数(LVMI)等。通过Logistic回归分析筛选发生CA-AKI的独立影响因素。
    结果 CA-AKI组患者N端脑钠肽前体(NT-proBNP)水平高于非CA-AKI组, 差异有统计学意义(P < 0.001)。与非CA-AKI组相比, CA-AKI组C反应蛋白、糖化血红蛋白(HbA1c)水平以及糖尿病和贫血患者占比较高, 差异有统计学意义(P < 0.05)。超声心动图数据显示, CA-AKI组LVMI、LVIDDI和LVIDSI均高于非CA-AKI组, 差异均有统计学意义(t=2.057、3.429、2.975;P < 0.05)。CA-AKI组左心室射血分数(LVEF)水平低于非CA-AKI组, 差异有统计学意义(t=3.005, P=0.003)。单因素Logistic回归分析显示, 糖尿病、贫血、炎症、NT-proBNP、HbA1c、LVMI、LVIDDI、LVIDSI、LVEF、心室肥厚、心室扩张与CA-AKI的发生显著相关(P < 0.05)。多因素Logistic回归分析结果显示, LVMI (OR=3.81;95% CI: 1.04~8.50;P=0.045)、LVIDDI (OR=4.21;95% CI: 2.02~6.08;P < 0.001)、LVIDSI (OR=1.61;95% CI: 1.27~2.03;P=0.024)、心室肥厚(OR=3.42;95% CI: 1.83~4.44;P=0.001)和心室扩张(OR=2.93;95% CI: 1.43~3.74;P=0.033)是发生CA-AKI的独立影响因素。
    结论 心脏重塑与CAD患者发生CA-AKI的风险显著相关。临床医师应及时对存在心脏结构异常的患者采取保护性措施, 以预防CA-AKI的发生。

     

    Abstract:
    Objective To explore the correlation between cardiac remodeling and the occurrence of contrast-associated acute kidney injury (CA-AKI) assessed by echocardiography.
    Methods A retrospective analysis was conducted on the clinical data of 100 patients with coronary artery disease (CAD) who underwent coronary angiography (CAG) and percutaneous coronary intervention (PCI) from March 2021 to March 2024.The patients were divided into CA-AKI group and non-CA-AKI group according to whether CA-AKI occurred.Baseline data and echocardiographic parameters, including left ventricular end-diastolic internal diameter index (LVIDDI), left ventricular end-systolic internal diameter index (LVIDSI), and left ventricular mass index (LVMI), were collected and compared between the two groups.Logistic regression analysis was used to screen for independent influencing factors of CA-AKI occurrence.
    Results The level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in the CA-AKI group was higher than that in the non-CA-AKI group, and the difference was statistically significant (P < 0.001).Compared with the non-CA-AKI group, the CA-AKI group had higher levels of C-reactive protein and glycosylated hemoglobin (HbA1c), as well as a higher proportion of patients with diabetes and anemia, and the differences were statistically significant (P < 0.05).Echocardiographic data showed that LVMI, LVIDDI, and LVIDSI in the CA-AKI group were all higher than those in the non-CA-AKI group, and the differences were statistically significant (t=2.057, 3.429, 2.975;P < 0.05).The left ventricular ejection fraction (LVEF) level in the CA-AKI group was lower than that in the non-CA-AKI group, and the difference was statistically significant (t=3.005, P=0.003).Univariate Logistic regression analysis showed that diabetes, anemia, inflammation, NT-proBNP, HbA1c, LVMI, LVIDDI, LVIDSI, LVEF, ventricular hypertrophy, and ventricular dilation were significantly associated with the occurrence of CA-AKI (P < 0.05).Multivariate Logistic regression analysis results showed that LVMI (OR=3.81;95% CI, 1.04 to 8.50;P=0.045), LVIDDI (OR=4.21;95% CI, 2.02 to 6.08;P < 0.001), LVIDSI (OR=1.61;95% CI, 1.27 to 2.03;P=0.024), ventricular hypertrophy (OR=3.42;95% CI, 1.83 to 4.44;P=0.001), and ventricular dilation (OR=2.93;95% CI, 1.43 to 3.74;P=0.033) were independent influencing factors for the occurrence of CA-AKI.
    Conclusion Cardiac remodeling is significantly correlated with the risk of CA-AKI in CAD patients.Clinicians should take protective measures timely for patients with abnormal cardiac structure to prevent the occurrence of CA-AKI.

     

/

返回文章
返回